Published in ACS Chem Neurosci on July 10, 2017
ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science (2012) 10.42
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Dopamine neuron agenesis in Nurr1-deficient mice. Science (1997) 5.40
A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell (2009) 4.60
Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature (2008) 3.44
Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell (2000) 3.01
Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature (2003) 2.81
Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet (2002) 2.27
Palladium-catalyzed borylation of aryl chlorides: scope, applications, and computational studies. Angew Chem Int Ed Engl (2007) 1.94
Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab (2010) 1.93
Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J (2000) 1.86
Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp Cell Res (1999) 1.51
Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function. Proc Natl Acad Sci U S A (2007) 1.48
Modulation of RXR function through ligand design. Biochim Biophys Acta (2011) 1.35
The retinoid X receptors and their ligands. Biochim Biophys Acta (2011) 1.32
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol (2005) 1.30
Structural basis for the cell-specific activities of the NGFI-B and the Nurr1 ligand-binding domain. J Biol Chem (2005) 1.21
Alternative inhibition of androgen receptor signaling: peptidomimetic pyrimidines as direct androgen receptor/coactivator disruptors. ACS Chem Biol (2009) 1.13
Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease. ACS Chem Neurosci (2013) 1.10
Nuclear receptors and their selective pharmacologic modulators. Pharmacol Rev (2013) 1.07
Counting on natural products for drug design. Nat Chem (2016) 1.05
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes. Endocrinology (2005) 1.01
NURR1 in Parkinson disease--from pathogenesis to therapeutic potential. Nat Rev Neurol (2013) 0.98
Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions. J Med Chem (2002) 0.97
Functions, therapeutic applications, and synthesis of retinoids and carotenoids. Chem Rev (2013) 0.96
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor. Bioorg Med Chem (2008) 0.95
Retinoic acid actions through mammalian nuclear receptors. Chem Rev (2013) 0.90
Characterisation of a novel NR4A2 mutation in Parkinson's disease brain. Neurosci Lett (2009) 0.89
Monitoring interactions between receptor tyrosine kinases and their downstream effector proteins in living cells using bioluminescence resonance energy transfer. Mol Pharmacol (2007) 0.88
Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders. Biochem Biophys Res Commun (2016) 0.85
Advances in drug design with RXR modulators. Expert Opin Drug Discov (2012) 0.85
Nuclear receptors in neurodegenerative diseases. Neurobiol Dis (2014) 0.85
Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease. BMC Neurosci (2009) 0.83
Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. Nat Commun (2015) 0.83
Selective allosteric ligand activation of the retinoid X receptor heterodimers of NGFI-B and Nurr1. Biochem Pharmacol (2005) 0.81
An Endogenous Mammalian Retinoid X Receptor Ligand, At Last! ChemMedChem (2016) 0.81
Modification at the Lipophilic Domain of RXR Agonists Differentially Influences Activation of RXR Heterodimers. ACS Med Chem Lett (2010) 0.81
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids. J Med Chem (2003) 0.81
RXR partial agonist produced by side chain repositioning of alkoxy RXR full agonist retains antitype 2 diabetes activity without the adverse effects. J Med Chem (2014) 0.80
Non-canonical modulators of nuclear receptors. Bioorg Med Chem Lett (2016) 0.79
A natural-product switch for a dynamic protein interface. Angew Chem Int Ed Engl (2014) 0.78
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease. Proc Natl Acad Sci U S A (2017) 0.78
Ab initio fragment molecular orbital study of molecular interactions between liganded retinoid X receptor and its coactivator: roles of helix 12 in the coactivator binding mechanism. J Phys Chem B (2007) 0.76
Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOE. Curr Top Med Chem (2017) 0.76
Synthetic retinoids: structure-activity relationships. Chemistry (2009) 0.76
Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation. J Med Chem (2016) 0.76
Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease. Oncotarget (2016) 0.75
Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors. FASEB J (2015) 0.75
Supramolecular Control over Split-Luciferase Complementation. Angew Chem Int Ed Engl (2016) 0.80
A Binary Bivalent Supramolecular Assembly Platform Based on Cucurbit[8]uril and Dimeric Adapter Protein 14-3-3. Angew Chem Int Ed Engl (2017) 0.76
Integrin-Targeting Fluorescent Proteins: Exploration of RGD Insertion Sites. Chembiochem (2017) 0.75
Small Molecule-Induced and Cooperative Enzyme Assembly on a 14-3-3 Scaffold. Chembiochem (2016) 0.75
Identification of two secondary ligand binding sites in 14-3-3 proteins using fragment screening. Biochemistry (2017) 0.75
Modulators of 14-3-3 Protein-Protein Interactions. J Med Chem (2017) 0.75
Supramolecular chemistry targeting proteins. J Am Chem Soc (2017) 0.75